Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Simon has been successful in her Wellcome Trust Investigator Award entitled: “Proteostasis and Autophagy in Immune Senescence.”

Katja Simon

Katja Simon, Professor of Immunology at the Kennedy Institute of Rheumatology has been awarded £1.8M over 5 years to explore the mechanics of autophagy and the role it plays in preventing ageing.

Healthcare challenges are intensifying as our population ages as age is the biggest single risk factor for many debilitating diseases, from infections to cancer. Immune ageing contributes by preventing useful immune responses as well as to other age-related diseases such as neurodegeneration, cardiovascular disease and cancer. But this process is little studied. Autophagy, a pathway activated when cells are stressed, clears away debris accumulated over time, recycling building blocks for re-use.

“Declining autophagy underpins ageing in many tissues, especially, as we have shown, in the immune system. We now want to identify what is degraded and what is generated by autophagy, to better understand how it prevents aging,” said Professor Simon. “I am delighted to receive this award as it will give my team and me the opportunity to study the underlying causes of aging both at a basic science level as well as trying to identify new drugs.

The award will enable Professor Simon to study how autophagy controls the amino acid pool and cellular energy levels and thereby protein synthesis. While protein synthesis levels decline with age, previous studies found that increasing the synthesis of autophagy proteins alone rejuvenates immune cells. By studying this pathway, they hope to identify new ways to prevent or even reverse the aging of immune cells.

Similar stories

New children’s orthopaedic hospital opens in Zimbabwe

Main

A new children’s orthopaedic hospital in Bulawayo that will treat children across Zimbabwe who are living with musculoskeletal impairments has opened today.

Professor Katja Simon elected to the Academy of Medical Sciences

Awards Kennedy Main

Professor of Immunology Katja Simon has been elected as a Fellow of the Academy of Medical Sciences.

3,400 different medicines used globally to treat COVID-19

Main Statistics and epidemiology

Insufficient data, and misleading recommendations led to significant early heterogeneity in global COVID-19 patient management, according to recent BMJ study

Clinical trial finds Azithromycin has no benefit against COVID-19

Main OCTRU

A clinical trial by University of Oxford researchers has confirmed that the antibiotic azithromycin has no clinical benefit in people with moderate COVID-19.

Study reveals the three most important aspects of care for hip fractures

Hip Main OCTRU Research Trauma

Older patients with hip fractures recover better if they receive treatment under the supervision of both a surgeon and a specialist in elderly care; are checked to avoid future falls; and are assessed for memory problems.

Major ERC funding awarded to Professor Michael Dustin

Awards Kennedy Main

Professor Michael Dustin and an international team of collaborators have been awarded a €10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.